Name
Alasdair Coles

CoPED ID
c320ef19-db70-48eb-9131-38edd4f62469

Email
None

OrcidID
None

LinkedIn URL

Projects in CoPED

A randomised placebo-controlled trial of immunotherapy in patients with psychosis associated with anti-neuronal membrane antibodies (SINAPPS 2)

Status: Active
Total funding: £4,939,666
From: July 31, 2016
To: March 31, 2024
Organisations: 3
People: 5



Organisations


Added to CoPED
April 11, 2022, 1:37 a.m.

Last update
Nov. 27, 2023, 1:20 p.m.